Completed PHASE4 INTERVENTIONAL 2-arm NCT01408979

Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia (MgSO4)

Postpartum Prophylaxis With Short Course Magnesium Sulfate in Severe Preeclampsia: a Randomized Clinical Trial

Sponsor: Instituto Materno Infantil Prof. Fernando Figueira

Interventions Magnesium sulfate 12 hours Magnesium sulfate 24 hours

Updated 5 times since 2017 Last updated: Aug 20, 2012 Started: Aug 31, 2011 Primary completion: Dec 31, 2011 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01408979, this PHASE4 trial focuses on Severe Preeclampsia and remains completed. Sponsored by Instituto Materno Infantil Prof. Fernando Figueira, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Materno Infantil Prof. Fernando Figueira

Data source: Instituto Materno Infantil Prof. Fernando Figueira

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Recife, Brazil